Corteva posts smaller quarterly loss
Agricultural chemical and seed company Corteva on Wednesday reported a smaller third-quarter loss on the back of higher
1970-01-01 08:00
Israel’s Teva Lifts Outlook With War Not Curbing Drug Production
Teva Pharmaceutical Industries Ltd., one of Israel’s largest companies, increased its revenue guidance for the second straight quarter,
1970-01-01 08:00
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
1970-01-01 08:00
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
By Blake Brittain Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5
1970-01-01 08:00
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholesterol to settle price-fixing charges from the US Department of Justice, the agency announced Monday.
1970-01-01 08:00
Berlusconi Office Backing $100 Million Pharma Startup Qualifyze
Qualifyze is closing in on a fundraising that could value the pharmaceutical compliance data firm at about $100
1970-01-01 08:00
Corteva profit beats expectations on higher seed prices
(Reuters) -Agricultural chemical and seed company Corteva beat Wall Street estimates for second-quarter profit on Thursday, benefiting from strong demand
1970-01-01 08:00
Gilead Recovers as Quarterly Revenue Reassures Investors
Gilead Sciences Inc. shares erased a decline as a strong quarterly performance more than offset a lower profit
1970-01-01 08:00
Teva agrees to pay $126 million to US hospitals over opioids
By Brendan Pierson Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals
1970-01-01 08:00
Private Equity Backers of Plan B Morning-After Pill Weigh $4 Billion Sale of Company
The private equity owners of Foundation Consumer Healthcare are exploring a potential sale of the company behind popular
1970-01-01 08:00
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
1970-01-01 08:00
Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
1970-01-01 08:00